摘要
目的:探讨结肠癌肝转移患者行手术治疗的效果以及患者的预后影响因素。方法:选取2010年2月至2015年1月5年间收治的结肠癌肝转移患者为研究对象,所有患者均进行手术治疗,治疗后对患者进行随访调查,观察随访1年、3年间患者的生存率,并且通过单因素分析影响患者预后的相关因素。结果:在120例结肠癌肝转移中,行单纯原发灶肿瘤切除患者1年、3年的生存率为47.87%、11.70%,行原发灶与肝转移灶均切除的患者1年、3年的生存率分别为65.38%、46.15%;单因素分析结果显示,肿瘤分化程度、CEA、肝转移灶切除、介入治疗、全身化疗是影响患者生存率的关键因素。结论:对于结肠癌肝转移患者而言,应尽快的采取手术根治的方法进行治疗,同时后续可采取介入治疗、全身化疗等方法来延长患者的生存周期。
Objective:To investigate the effect ofclinicopathologic parameters on prognosis of liver metastasis from colon cancer.Methods:Patients with colorectal cancer liver metastases from February 2010 to January 2015 were enrolled in this study.All patients underwent surgical treatment.The patients were followed up for 1 year and 3 years.Survival time and the univariate analysis were used to check the prognosis of patients related factors.Results:The 1-year survival rate and 3-year survival rate of patients with primary tumor resection was 47.87%and 11.70%respectively.However,The 1-year survival rate and 3-year survival rate of patientsundergoing primary and liver metastasis tumor resection was 65.38%and 46.15%.The results show that the degree of tumor differentiation,CEA,liver resection,interventional therapy and systemic chemotherapy are important factors forprognosis of patients.Conclusion:Patients with liver metastases of colon cancer should be treated with radical surgery as soon as possible,following with intervention therapy,systemic chemotherapy and other methods to promote the survival time.
作者
孙志德
程利民
SUN Zhide;CHENG Limin(The Affiliated Hospital of Chengde Medical College,Heibei Chengde 067000,China)
出处
《河北医学》
CAS
2019年第7期1151-1154,共4页
Hebei Medicine
关键词
结肠癌肝转移
手术治疗
预后
Colon cancer Liver metastasis
Surgical treatment
Prognosis